Moonlake Immunotherapeutics
MLTX
Revenue
0.00
0.000.00%
-Assets
477.93M
▼-40.28M▼-7.77%
3 Months ChangeLiabilities
24.54M
▲1.83M▲8.06%
3 Months ChangeFree Cash Flow
-15.16M
▼-6.14M▼-67.99%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-11
Form 8-K
ID: 0001213900-24-077513
2024-08-07
Form 10-Q
ID: 0001821586-24-000025
2024-08-07
Form 8-K
ID: 0001821586-24-000024
2024-06-10
Form 8-K
ID: 0001213900-24-051263
2024-06-06
Form 8-K
ID: 0001213900-24-050194
2024-05-07
Form 10-Q
ID: 0001821586-24-000020
2024-05-07
Form 8-K
ID: 0001821586-24-000019
2024-03-11
Form 8-K
ID: 0001213900-24-021233
2024-02-29
Form 8-K
ID: 0001821586-24-000007
2024-02-26
Form 8-K
ID: 0001213900-24-016737